Lek d.d.

Newsletters

TOPICS

COUNTRIES

INDUSTRY

LOGIN

Home

Companies

Lek d.d.

Country

Slovenia

Industry

Pharmaceuticals

Owner

Novartis International AG

See top 100 rank

Assets

1,148,918,000

Currency

EUR

Year

2023

Profit

135,705,000

Revenue

1,649,043,000

Employees

4,006

FULL COMPANY PROFILE

Latest news

Slovenia's Lek opens 90 mln euro development centre in Ljubljana

Jun 17, 2026

June 17 (SeeNews) - Slovenian pharmaceutical company Lek, owned by Switzerland's Sandoz, said on Wednesday it inaugurated a 90 million euro ($104 million) biosimilar development centre in Ljubljana.

Slovenia to aid Lek's high-tech project with up to 42 mln euro grant

Dec 5, 2025

Lek starts works on 400 mln euro biosimilars plant in Brnik

Jul 2, 2025

Slovenia's Lek breaks ground for $90 mln biosimilars centre

Apr 22, 2024

Slovenia's Lek to start building biosimilars plant in April - report

Mar 19, 2024

all stories about the company

more for country

more for top100

more for this industry

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.

About

SeeNews is your complete guide to the emerging economies of Southeast Europe. Latest news, market intelligence, industry analyses, on-demand research – the big picture at the tip of your fingers.

More about SeeNews

Premium access

Get ahead of the competition with SeeNews Premium Access. Unlimited news and objective analysis you can trust, company data and more. Subscribe now and start making agile business decisions.